Skip to content

Glycemic Index- GI of Big Basket Low GI Aata

To estimate the Glycemic Index- GI of Big Basket Low GI Aata - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094971
Enrollment
10
Registered
2025-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: Food product(s):Big basket aata: Test Product: Food product(s):Big basket aata Dose: Take 65.05 g of Aata and make chappati have it with water in 12-15 min, Route of Admi

Sponsors

Innovative retail concept pvt ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Gender: Either male or non-pregnant, non-lactating female aged 18-60 years. 2) Subjects willing to give written informed consent 3) Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 4) Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 5) Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1.Diabetic Patients. 2.Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study. 3.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition. 4.Have open sores or open lesions in the treatment area(s). 5.Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of such food product. 6.Have participated in any interventional clinical trial in the previous 30 days. 7.Have a known sensitivity to any of the constituents of the test product including sensitivities(mention some of active ingredient s name). 8.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids. 9.Have a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past 2 years.

Design outcomes

Primary

MeasureTime frame
Blood Glucose AssessmentTimepoint: At t+0min, t+15min, t+30min, t+45min, t+60min, t+90min, and t+120 minutes

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026